Mechanisms of Pilocarpine-Induced Nitric Oxide and Prostaglandin Production in Porcine Ciliary Muscle. [PDF]
Pilocarpine activates M1 and M3 muscarinic receptors in porcine ciliary muscle, engaging calcium‐dependent phospholipase C (PLC), nitric oxide synthase (NOS), and cyclooxygenase (COX) pathways that increase prostaglandin E2 (PGE2) synthesis. Beyond nitric oxide (NO) modulation, PGE2 emerges as a key mediator linking muscarinic signaling to ciliary ...
Benozzi G +3 more
europepmc +2 more sources
We conducted a two-part controlled study to evaluate the efficacy of preoperative oral pirenzepine (muscarinic receptor antagonist known to inhibit gastric secretion), ranitidine, and the combination pirenzepine-ranitidine in controlling gastric fluid pH and volume in 210 ASA I children, aged 2-14 yr, undergoing elective surgery.
N, Maekawa +4 more
openaire +2 more sources
Use of Clinical Pharmacology in Slowing the Myopia Epidemic. [PDF]
Novack GD.
europepmc +1 more source
Topical application of the antimuscarinic pirenzepine increased lower limb nerve fibre density in a phase 2a study in type 2 patients with diabetes with peripheral neuropathy. [PDF]
Sivadasan A +12 more
europepmc +1 more source
The Induction of Long-Term Potentiation by Medial Septum Activation under Urethane Anesthesia Can Alter Gene Expression in the Hippocampus. [PDF]
Dobryakova YV +7 more
europepmc +1 more source
Pharmacological Characterization of Vasomotor Responses in the Tree Shrew (<i>Tupaia belangeri</i>) Basilar Artery: A Promising Model for Human Cerebrovascular Research. [PDF]
Islam MZ +4 more
europepmc +1 more source
Blood disorders associated with pirenzepine. [PDF]
B H, Stricker +3 more
openaire +2 more sources
Modern Methods for Preventing the Progression of Myopia in Children. [PDF]
Pniakowska Z +4 more
europepmc +1 more source
Muscarinic Receptor Antagonism and TRPM3 Activation as Stimulators of Mitochondrial Function and Axonal Repair in Diabetic Sensorimotor Polyneuropathy. [PDF]
Chauhan S, Calcutt NA, Fernyhough P.
europepmc +1 more source

